Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. (300501.SZ)
CNY 14.41
(-0.07%)
CNY 14.41
(-0.07%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 158.56 Million CNY | 623.21% |
| 2022 | -30.3 Million CNY | 88.32% |
| 2021 | -259.52 Million CNY | -221.82% |
| 2020 | 213.04 Million CNY | 51.71% |
| 2019 | 140.42 Million CNY | 404.09% |
| 2018 | 27.85 Million CNY | 128.95% |
| 2017 | -96.24 Million CNY | 1.06% |
| 2016 | -97.27 Million CNY | -59.03% |
| 2015 | -61.16 Million CNY | 14.38% |
| 2014 | -71.44 Million CNY | -130.59% |
| 2013 | -30.98 Million CNY | -113.81% |
| 2012 | -14.49 Million CNY | -2.02% |
| 2011 | -14.2 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 194.67 Million CNY | 22.77% |
| 2024 Q2 | 330 Million CNY | 69.51% |
| 2024 Q3 | 283.22 Million CNY | -14.11% |
| 2023 Q2 | 105.29 Million CNY | 206.91% |
| 2023 FY | 158.56 Million CNY | 623.21% |
| 2023 Q4 | 158.56 Million CNY | -0.77% |
| 2023 Q1 | -98.49 Million CNY | -224.99% |
| 2023 Q3 | 159.79 Million CNY | 51.76% |
| 2022 Q2 | -50.35 Million CNY | 43.62% |
| 2022 FY | -30.3 Million CNY | 88.32% |
| 2022 Q4 | -30.3 Million CNY | 39.11% |
| 2022 Q3 | -49.77 Million CNY | 1.16% |
| 2022 Q1 | -89.3 Million CNY | 65.59% |
| 2021 Q1 | 240.82 Million CNY | 13.04% |
| 2021 FY | -259.52 Million CNY | -221.82% |
| 2021 Q3 | -332.38 Million CNY | -231.3% |
| 2021 Q4 | -259.52 Million CNY | 21.92% |
| 2021 Q2 | 253.13 Million CNY | 5.11% |
| 2020 FY | 213.04 Million CNY | 51.71% |
| 2020 Q4 | 213.04 Million CNY | 33.17% |
| 2020 Q3 | 159.98 Million CNY | 23.07% |
| 2020 Q2 | 129.99 Million CNY | 3.81% |
| 2020 Q1 | 125.22 Million CNY | -10.83% |
| 2019 Q2 | 57.67 Million CNY | -16.6% |
| 2019 Q1 | 69.15 Million CNY | 148.25% |
| 2019 FY | 140.42 Million CNY | 404.09% |
| 2019 Q3 | 103.27 Million CNY | 79.05% |
| 2019 Q4 | 140.42 Million CNY | 35.98% |
| 2018 Q2 | -41.26 Million CNY | -14.49% |
| 2018 Q1 | -36.03 Million CNY | 70.06% |
| 2018 FY | 27.85 Million CNY | 128.95% |
| 2018 Q4 | 27.85 Million CNY | 193.37% |
| 2018 Q3 | -29.83 Million CNY | 27.69% |
| 2017 Q4 | -120.36 Million CNY | -115.77% |
| 2017 Q2 | -80.87 Million CNY | 29.36% |
| 2017 FY | -96.24 Million CNY | 1.06% |
| 2017 Q3 | -55.78 Million CNY | 31.02% |
| 2017 Q1 | -114.48 Million CNY | -17.7% |
| 2016 Q4 | -97.27 Million CNY | -79.98% |
| 2016 FY | -97.27 Million CNY | -59.03% |
| 2016 Q2 | -136.81 Million CNY | 52.19% |
| 2016 Q3 | -54.04 Million CNY | 60.5% |
| 2016 Q1 | -286.18 Million CNY | -203.57% |
| 2015 Q4 | -94.27 Million CNY | -79.29% |
| 2015 Q3 | -52.58 Million CNY | 0.0% |
| 2015 Q1 | 71.44 Million CNY | 0.0% |
| 2015 FY | -61.16 Million CNY | 14.38% |
| 2014 FY | -71.44 Million CNY | -130.59% |
| 2013 FY | -30.98 Million CNY | -113.81% |
| 2012 FY | -14.49 Million CNY | -2.02% |
| 2011 FY | -14.2 Million CNY | 0.0% |